Yeh E Ann, Graves Jennifer S, Benson Leslie A, Wassmer Evangeline, Waldman Amy
From the Division of Neurology (E.A.Y.), Hospital for Sick Children, Hospital for Sick Children Research Institute, Department of Pediatrics, University of Toronto, Ontario, Canada; Department of Neurology (J.S.G.), University of California, San Francisco; Department of Neurology (L.A.B.), Boston Children's Hospital, Boston, MA; Department of Neurology (E.W.), Birmingham Children's Hospital, Birmingham, UK; and Department of Neurology (A.W.), The Children's Hospital of Philadelphia, PA.
Neurology. 2016 Aug 30;87(9 Suppl 2):S53-8. doi: 10.1212/WNL.0000000000002822.
Optic neuritis (ON) is a common presenting symptom in pediatric CNS demyelinating disorders and may be associated with dramatic visual loss. Knowledge regarding clinical presentation, associated diseases, therapy, and outcomes in ON in children has grown over the past decade. These studies have shown that younger children (<10 years of age) are more likely to present with bilateral ON and older children with unilateral ON. Furthermore, studies focusing on visual recovery have shown excellent recovery of high-contrast visual acuity in the majority of children, but functional and structural studies have shown evidence of irreversible injury and functional decline after ON in children. Although randomized controlled treatment trials have not been performed in children and adolescents with ON, standard of care suggests that the use of high-dose pulse steroids is safe and likely effective. This article reviews current knowledge about the clinical presentation and management of pediatric ON, with attention to associated syndromes and evaluative tools that may inform diagnosis and interventions.
视神经炎(ON)是儿童中枢神经系统脱髓鞘疾病常见的首发症状,可能伴有严重的视力丧失。在过去十年中,关于儿童视神经炎的临床表现、相关疾病、治疗及预后的知识不断增加。这些研究表明,年幼儿童(<10岁)更易出现双侧视神经炎,而年长儿童则多为单侧视神经炎。此外,专注于视力恢复的研究显示,大多数儿童的高对比度视力可实现良好恢复,但功能和结构研究表明,儿童视神经炎后存在不可逆损伤和功能衰退的证据。尽管尚未对儿童和青少年视神经炎患者进行随机对照治疗试验,但护理标准表明,使用大剂量脉冲类固醇是安全且可能有效的。本文综述了有关儿童视神经炎临床表现和管理的当前知识,重点关注可能为诊断和干预提供依据的相关综合征及评估工具。